Stocks and securities in focus
Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | -7.140% | -4.337% | 2.549% | 230.818% | 291.078% | 1342.616% | - |
Chromadex Corp | -1.120% | -2.286% | -6.044% | 155.224% | 155.224% | -44.839% | - |
Powell Industries Inc. | 3.500% | 5.182% | 23.362% | 228.361% | 92.963% | - | - |
Novavax Inc. | 97.310% | 80.837% | 108.011% | 0.917% | 84.927% | -93.750% | 26.254% |
Inogen Inc. | 2.610% | 22.901% | 12.587% | -21.078% | 51.887% | -85.364% | - |
Cytomx Therapeutics Inc | -15.850% | -55.310% | -5.969% | 10.890% | 32.020% | -72.574% | - |
Ocular Therapeutix Inc. | -5.620% | -8.170% | -28.513% | -10.923% | 25.357% | -57.920% | 62.396% |
Ardelyx Inc. | -3.860% | -10.646% | 8.770% | 81.814% | 24.879% | 33.667% | - |
Mersana Therapeutics | -3.750% | -21.620% | -27.051% | -65.843% | 19.242% | -80.794% | - |
Perficient Inc. | -0.730% | 52.902% | 43.305% | 1.844% | 12.590% | - | - |
Biolife Solutions Inc | -3.510% | -0.602% | 3.774% | -2.941% | 10.738% | -36.392% | 14.329% |
Fate Therapeutics Inc. | 9.850% | 0.317% | -38.485% | -21.923% | 6.665% | -93.920% | - |
Akebia Therapeutics Inc. | -5.620% | -12.373% | -22.668% | 19.807% | -4.522% | -53.375% | - |
Catalyst Pharmaceutical Partners Inc | 0.380% | 5.679% | 1.684% | -7.183% | -4.794% | 272.201% | 409.470% |
Travelzoo Inc. | -1.840% | -0.621% | -13.978% | 8.844% | -7.514% | -44.056% | -55.782% |
Asure Software | -1.480% | 2.308% | -4.317% | -49.237% | -21.765% | 2.308% | 3.165% |
Cytokinetics Inc. | -0.840% | -4.918% | -16.547% | 66.667% | -24.183% | 198.969% | - |
Salarius Pharmaceuticals Inc. | 2.480% | -8.811% | 2.985% | -70.216% | -25.405% | -98.392% | -99.993% |
Plug Power Inc. | -7.290% | -6.651% | -16.859% | -66.713% | -44.228% | -85.675% | 12.524% |
MacroGenics Inc. | -77.710% | -78.352% | -81.918% | -53.424% | -65.844% | -88.752% | - |
Apellis Pharmaceuticals | -1.890% | - | - | - | - | - | - |
Revance Therapeutics Inc. | -22.280% | - | - | - | - | - | - |
Blue Bird Corp | 3.230% | - | - | - | - | - | - |